Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology ◽

10.1053/j.gastro.2021.07.049 ◽

2021 ◽

Author(s):

Fasiha Kanwal ◽

Jay H. Shubrook ◽

Leon A. Adams ◽

Kim Pfotenhauer ◽

Vincent Wai-Sun Wong ◽

...

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Care Pathway ◽

Clinical Care ◽

Nonalcoholic Fatty Liver ◽

Clinical Care Pathway

Download Full-text

Correspondence on Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease

Gastroenterology ◽

10.1053/j.gastro.2022.01.013 ◽

2022 ◽

Author(s):

Shelby Sullivan ◽

Pichamol Jirapinyo ◽

Vivek Kumbhari

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Care Pathway ◽

Clinical Care ◽

Nonalcoholic Fatty Liver ◽

Clinical Care Pathway

Download Full-text

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe

International Journal of Cardiology ◽

10.1016/j.ijcard.2018.05.087 ◽

2018 ◽

Vol 270 ◽

pp. 245-252 ◽

Author(s):

Tracey G. Simon ◽

Kathleen E. Corey ◽

Christopher P. Cannon ◽

Michael Blazing ◽

Jeong-Gun Park ◽

...

Keyword(s):

Cardiovascular Risk ◽

Liver Disease ◽

Risk Stratification ◽

Secondary Prevention ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Fibrosis Score ◽

Nonalcoholic Fatty Liver ◽

Nafld Fibrosis Score

Download Full-text

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.15640 ◽

2020 ◽

Vol 51 (6) ◽

pp. 661-662 ◽

Author(s):

Abdel-Aziz Shaheen ◽

Mark G. Swain

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Nonalcoholic Fatty Liver ◽

Risk Stratification Tool

Download Full-text

Evaluating a clinical care pathway for the screening, diagnosis and treatment of fatty liver disease among primary care patients

http://isrctn.com/ ◽

10.1186/isrctn46342829 ◽

2020 ◽

Author(s):

Christos Lionis

Keyword(s):

Primary Care ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Care Pathway ◽

Clinical Care ◽

Diagnosis And Treatment ◽

Primary Care Patients ◽

Clinical Care Pathway

Download Full-text

One-minute liver "digitopsy" for point of care risk stratification of fibrosis in nonalcoholic fatty liver disease

Minerva Gastroenterology ◽

10.23736/s2724-5985.20.02700-2 ◽

2021 ◽

Vol 67 (2) ◽

Author(s):

Andrea SALMI

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Point Of Care ◽

Nonalcoholic Fatty Liver

Download Full-text

Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease

Digestive and Liver Disease ◽

10.1016/j.dld.2021.02.003 ◽

2021 ◽

Author(s):

Tingfeng Wu ◽

Junzhao Ye ◽

Xiaorong Gong ◽

Xin Li ◽

Congxiang Shao ◽

...

Keyword(s):

Cardiovascular Disease ◽

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Disease Risk ◽

Cardiovascular Disease Risk ◽

Nonalcoholic Fatty Liver ◽

Liver Parameters

Download Full-text

The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease

Endocrinology Diabetes & Metabolism ◽

10.1002/edm2.127 ◽

2020 ◽

Vol 3 (4) ◽

Author(s):

Jose Hernandez Roman ◽

Mohammad S. Siddiqui

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Nonalcoholic Fatty Liver ◽

Noninvasive Biomarkers

Download Full-text

Noninvasive risk stratification in nonalcoholic fatty liver disease: a polygenic risk score

Digestive and Liver Disease ◽

10.1016/j.dld.2019.12.024 ◽

2020 ◽

Vol 52 ◽

pp. e9-e10

Author(s):

C. Bianco ◽

S. Pelusi ◽

G. Baselli ◽

I. Zanoni ◽

A. Taliento ◽

...

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Polygenic Risk Score ◽

Nonalcoholic Fatty Liver ◽

Download Full-text

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.15651 ◽

2020 ◽

Vol 51 (6) ◽

pp. 662-663

Author(s):

Dae Won Jun ◽

Mindie H. Nguyen

Keyword(s):

Liver Disease ◽

Risk Stratification ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Nonalcoholic Fatty Liver ◽

Risk Stratification Tool

Download Full-text

Nonalcoholic fatty liver disease: The most common cause of abnormal liver enzymes in the U.S. population

Gastroenterology ◽

10.1016/s0016-5085(01)80321-8 ◽

2001 ◽

Vol 120 (5) ◽

pp. A65-A65 ◽

Author(s):

J CLARK ◽

F BRANCATI ◽

A DIEHL

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Liver Enzymes ◽

Common Cause ◽

Nonalcoholic Fatty Liver ◽

Download Full-text